Do you add trastuzumab to adjuvant chemotherapy for patients with Her2+ stage I-II high grade serous uterine cancer following surgical staging?
Or would you reserve its use to stage III-IV or recurrent disease (as in Fader et al., PMID 29584549)?
Community PollStarted
In what circumstances do you administer trastuzumab for uterine serous carcinoma?
68 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Gynecologic Oncology · Center of Hope
Answered on
No, I don’t routinely add trastuzumab to adjuvant chemotherapy for early stage Her2+ serous endometrial cancer patients. There are no data supporting its use in this manner. My recommendation is to offer her treatment on GY026, a study enrolling both early and late-stage serous endometrial cancer pa...
Join for free or sign in to see the full answer